Efficacy and Safety of Bone Marrow Cell Transplantation for Chronic Ischemic Heart Disease: A Meta-Analysis

@inproceedings{Xiao2014EfficacyAS,
  title={Efficacy and Safety of Bone Marrow Cell Transplantation for Chronic Ischemic Heart Disease: A Meta-Analysis},
  author={Chun Xiao and Shijie Zhou and Yueqiang Liu and Huozhen Hu},
  booktitle={Medical science monitor : international medical journal of experimental and clinical research},
  year={2014}
}
BACKGROUND Although bone marrow-derived cells (BMCs) have shown great therapeutic potential in patients with chronic ischemic heart disease (CIHD), the exact efficacy and safety of BMCs therapy is still not completely defined. MATERIAL/METHODS We searched PubMed, OVID, EMBASE, the Cochrane Library, and ClinicalTrials.gov and finally identified 20 qualified trials in this meta-analysis. Assessment of efficacy was based on left ventricular ejection fraction (LVEF), left ventricular end-systolic… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Effects of exercise training and stem cell therapy on the left ventricle of infarcted rats.

VIEW 2 EXCERPTS
CITES BACKGROUND

Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies

VIEW 1 EXCERPT
CITES RESULTS

References

Publications referenced by this paper.
SHOWING 1-10 OF 41 REFERENCES

Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass.

VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL